Synedica Retatrutide 40mg

Retatrutide is a triple agonist targeting GLP-1, GIP, and Glucagon receptors. This comprehensive research peptide comes in a 40mg pen containing 4 disposable 10mg doses with 12 needles and instruction materials. Designed for research purposes by Synedica, Retatrutide represents cutting-edge peptide science for longevity and metabolic research. Once-weekly administration protocol. Each box includes complete documentation and Certificate of Analysis.